Nutritional, Metabolic, Endocrine
Conditions
Interventions
Locally prepared therapeutic formula
standard therapeutic formula
Sponsors
Tamimu Yakubu
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: SAM children between 6–59 months without allergies to milk or legumes (i.e. peanut) Children admitted at the ward Stable SAM cases
Exclusion criteria
Exclusion criteria: Children will be excluded if they are involved in another research trial or feeding program Children with chronic debilitating illness (e.g., cerebral palsy or congenital malformations) Children with history of peanut or milk allergy.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary outcome will be recovery (defined as MUAC= 12.5 cm, medical complications resolved/resolving and WHZ=-2 SD of the WHO standards and reduced/absence of oedema of feet). | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary outcomes included weight gain, length/height gain, LOS, prevalence of diarrhoea, WFH, WFA, HFA and mortality. Also iron, zinc and vitamin A will be assessed including analysis of total protein, albumin, C-reactive protein as well as pro-inflammatory cytokines. | — |
Countries
Ghana
Contacts
Public ContactHawa Alhassan
Secretary
Outcome results
None listed